Triplixam 5 mg/1,25 mg/5 mg filmom obložene tablete
| Name | Triplixam 5 mg/1,25 mg/5 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-385858036 |
| Active Substance | perindoprilarginin indapamid amlodipinbesilat |
| Composition | jedna filmom obložena tableta sadrži 3,395 mg perindoprila što odgovara 5 mg perindoprilarginina, 1,25 mg indapamida i 6,935 mg amlodipinbesilata što odgovara 5 mg amlodipina |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Les Laboratoires Servier Industrie, Gidy, Francuska Servier (Ireland) Industries Ltd., Arklow, Co. Wicklow, Irska Egis Pharmaceuticals Private Limited Company (PLC), Kormend, Mađarska Anpharm Przedsiebiorstwo Farmaceutyczne S.A., Varšava, Poljska |
| Marketing Authorisation Holder | Servier Pharma d.o.o., Ulica Grge Tuškana 37, Zagreb, Hrvatska |
| Marketing Authorisation Date | 15.04.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/18-02/96 |
| Registration Number | 381-12-01/30-19-03 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | C09BX01 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
